With the growth of the global population (7.920 billion, Jan 2022), the number of older adults (age 65 and older) will also increase when it reaches 1.5 billion by 2050. There is a parallel increase in life expectancy across many countries in the rapidly expanding older adult age stratum. Older adults are aging in place/independent residence, remaining in the workforce longer, and actively participating in their communities. In a similar vein, older drivers are one of the fastest-growing groups, representing a significant proportion of all drivers. In the United States, older adults age ≥ 65 will constitute 25% of all drivers by 20501. In Europe and Japan, older drivers will make up a quarter of all drivers much earlier (2030)2. In Brazil, estimates of older drivers follow similar trends and range from 22-35%3. Conversely, motor vehicle crashes kill 1.35 million persons annually, are the eighth leading cause of death across all ages, cost $1.8 trillion (2010 USD) annually, and differentially impact low and middle income countries financially, along with a higher death rate4. Older adults are at the highest risk for injuries and mortality as a result of physiological decline and fragility.
Driving is a multifaceted and dynamic activity that demands instantaneous, sustained, and synchronized deployment of sen sorimotor, cognitive, and affective systems. The coordination across multisystemic functions occurs in response to a rapidly changing environment with numerous stimuli (e.g., weather, road conditions, light, other drivers) while coping with internal conditions like stress, fatigue, and sleepiness. Despite driving being an overlearned task, age-related decline may moderately impact abilities (e.g., reaction time, strength, range-of-motion, sensation) that support the vehicle-driver task interface. While these modest and gradual changes may limit driving performance, they do not impact driving safety. However, chronic conditions like arthritis, cerebrovascular disease, neuropathy, cataracts, and dementia impair and increase the risk of crashes, related injury, and mortality among older drivers. As a result, significant research efforts aim to assess driving decline and identify risk factors among healthy and cognitively-normal (CN) older drivers.
Vasques and colleagues used an asymptomatic5, healthy cadre of older adults to determine whether common neuropsychological assessments were associated with high-risk driving conditions on a driving simulator. The simulator scenarios included navigating a complex intersection, overtaking another vehicle, navigating in rain, and dealing with a vehicle malfunction. Older drivers identified as high-risk exhibited more errors (or penalties) on the intersection, overtaking, and rain performance scenarios that confirm and validate the cognitive demand of those tasks. The Rey Auditory-Verbal Learning Test (RAVLT) was able to distinguish between older drivers, and scores were significantly lower among those classified as high risk compared to those at normal risk. The RAVLT assesses attention, learning, and short-term memory (encoding, storage, retrieval). Since the simulator scenarios were novel and not experienced before, the participants had to learn and react to the new task with minimal practice. As expected, the inverse correlation between low RAVLT scores and higher errors/penalties on the simulator tasks corroborate the innate learning, memory, and attentional skills required of both tasks. Unsurprisingly, general cognitive screens like the Mini-Mental State Examination (MMSE) and Addenbrooke's Cognitive Evaluation (ACE) were not associated with any group differences.
For decades, the search has endured for a single or multidomain neuropsychological test or a composite score that may forecast or provide prescient knowledge of crash risk or driving decline. Measures of visuomotor, attentional control, and/or executive function (e.g., Trail Making Test) can predict an increased likelihood of crash risk among those with mild cognitive impairment and prodromal dementia6. However, this pattern does not hold for cognitively-normal older adults. In studies of CN older adults and Alzheimer’s disease biomarkers, those with more abnormal biomarker levels made two-and-a-half more errors and were faster to fail a road test compared to those with normal biomarkers7,8. However, there no differences between independent neuropsychological measures or a composite z-score between the groups. The null findings with cognitive tasks were also found in a longitudinal study of naturalistic daily driving behavior9 and a study of depression and driving performance10. General screenings like the MMSE or ACE were never designed to assess the hierarchical complexity of driving. Even multidomain measurements like the RAVLT may not capture the cognitive load and sensorimotor process integration that driving demands.
Assessment of driving decline among older adults is nuanced and can be conducted across controlled platforms like road tests and driving simulators or in daily driving via GPS dataloggers. Multimorbidity, medications, and the prescribing cascade may further obscure the sensitivity and specificity of assessing impairments. While general screens like the MMSE may not be clinically informative, multidomain measurements like the RAVLT, as shown by Vasques and colleagues, can provide insight into process-specific impairments. As a result, associations between these impairments and performance on a driving simulator may provide data on the likelihood of safe driving. Other approaches may include a combination of different risk factors like demographics (e.g., age), a composite z-score, biomarkers, self-report, and objective driving behavior to predict status and trajectory of driving decline. Driving performance (simulator, road test) and driving behavior (naturalistic) are complex sets of cognitive processes that topographically overlap, interact, and rapidly shift in response to internal and external stimuli as an individual navigates a route or trip. Assessment should be comprehensive and encompass subjective, objective, and collateral metrics of driving behavior, multidomain assessment of cognitive functioning, and the older driver’s expectations about and motivation to drive11.
Acknowledgments
Dr. Babulal is supported by the National Institute of Health (NIH) and National Institute on Aging (NIH/NIA) grants R01AG068183, R01AG056466, R01AG067428, R01AG074302, BrightFocus Foundation A2021142S.
References
- The Federal Interagency Forum on Aging-Related Statistics . Older Americans 2016: Key indicators of well-being. Federal Interagency Forum on Aging-Related Statistics; 2016. [Google Scholar]
- Zhao Y, Yamamoto T. Review of Studies on Older Drivers’ Behavior and Stress-Methods, Results, and Outlook. Sensors (Basel) 2021;21(10):3503. doi: 10.3390/s21103503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hauser E, Barbosa AR, Pfützenreuter AH. Prevalence of older drivers in Brazil: results from Vigitel 2018. Gerontol Aging. 2020;14(4):267–273. doi: 10.5327/Z2447-212320202000089. [DOI] [Google Scholar]
- World Health Organization . Global status report on road safety 2015. World Health Organization; 2015. [Google Scholar]
- Vasques AM, Borelli WV, Pinho MS, Portuguez MW. Healthy older adults with high-risk driving associated with decreased learning score in different driving settings. Arq Neuro-Psiquiatr. 2022;80(1):30–36. doi: 10.1590/0004-282X-ANP-2021-0054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carr DB, Ott BR. The older adult driver with cognitive impairment:“It’s a very frustrating life”. JAMA. 2010;303(16):1632–1641. doi: 10.1001/jama.2010.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, et al. Preclinical Alzheimer’s disease and longitudinal driving decline. Alzheimers Dement (N Y) 2017;3(1):74–82. doi: 10.1016/j.trci.2016.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, et al. Amyloid imaging, cerebrospinal fluid biomarkers predict driving performance among cognitively normal individuals. Alzheimer Dis Assoc Disord. 2017;31(1):69–72. doi: 10.1097/WAD.0000000000000154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roe CM, Stout SH, Rajasekar G, Ances BM, Jones JM, Head DM, et al. A 2.5 Year longitudinal assessment of naturalistic driving in preclinical Alzheimer Disease. J Alzheimers Dis. 2019;68(4):1625–1633. doi: 10.3233/JAD-181242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Babulal GM, Chen S, Williams MM, Trani J-F, Bakhshi P, Chao GL, et al. Depression and Alzheimer’s disease biomarkers predict driving decline. J Alzheimers Dis. 2018;66(3):1213–1221. doi: 10.3233/JAD-180564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Babulal GM, Vivoda J, Harmon A, Carr DB, Roe CM, Zikmund-Fisher B. Older adults’ expectations about mortality, driving life and years left without driving. J Gerontol Soc Work. 2019;62(8):912–929. doi: 10.1080/01634372.2019.1663460. https://doi.org/ 10.1080/01634372.2019.1663460 [DOI] [PMC free article] [PubMed] [Google Scholar]